Clinical Trials Browser

Phase 2 × Anxiety Disorders × Minocycline × Clear all

NCT02203552 2025-01-08

Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer

Phase 2 Completed

56 enrolled 9 charts

Anxiety Disorders, Breast Neoplasms, Depression